We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Plant Extract Prevents Bacterial Skin Infections by Disrupting Quorum Sensing

By LabMedica International staff writers
Posted on 30 Aug 2015
An extract prepared from the leaves of the European chestnut Castanea sativa, a stalwart of Mediterranean region folk medicine, has been found to efficiently block the virulent effects of Staphylococcus aureus by preventing toxin production rather than by killing the organism.

Research on medical folklore in several Mediterranean countries led investigators from Emory University (Atlanta, GA, USA) to the European chestnut. More...
Extracts from the leaves of this plant had long been used by locals to wash their skin as a treatment for skin infections and inflammations.

In the laboratory, the investigators evaluated the extract for ability to block Staphylococcus aureus infection and ultimately identified more than 94 compounds. One fraction, enriched with derivatives of the triterpenes ursene and oleanene, was found to be particularly effective in preventing S. aureus infection while not actually killing the bacteria.

The investigators found that this fraction actually blocked the organism's quorum sensing inhibitory activity. Quorum sensing is a mechanism used by pathogenic bacteria not only to modulate virulence factor production but also to adapt to the metabolic demands of living in communities. Quorum-sensing systems have been shown to be key virulence regulators in both gram-negative and gram-positive pathogens. It has been suggested that quorum sensing represents a novel target for the development of agents to treat or prevent bacterial infections.

Results published in the August 21, 2015, online edition of the journal PLOS ONE presented evidence of the extract's Staphylococcus aureus accessory gene regulator (agr) allele blocking activity, as measured in toxin outputs, reporter assays hemolytic activity, cytotoxicity studies, and an in vivo abscess model. The results demonstrated the extract’s lack of cytotoxicity to human keratinocytes and murine skin, as well as lack of growth inhibitory activity against S. aureus and a panel of skin commensals. In addition, they showed that serial growth of the bacteria in the presence of the extract did not result in acquisition of resistance to the quorum quenching effect.

"We were able to trace out the pathways in the lab, showing how our botanical extract blocks quorum sensing and turns off toxin production entirely," said first author Dr. Cassandra Quave, assistant professor of biology at Emory University. "Many pharmaceutical companies are working on the development of monoclonal antibodies that target just one toxin. This is more exciting because we have shown that with this extract, we can turn off an entire cascade responsible for producing a variety of different toxins."

"We have identified a family of compounds from this plant that have an interesting medicinal mechanism," said Dr. Quave. "Rather than killing staph, this botanical extract works by taking away staph's weapons, essentially shutting off the ability of the bacteria to create toxins that cause tissue damage. In other words, it takes the teeth out of the bacteria's bite. It is easy to dismiss traditional remedies as old wives' tales, just because they do not attack and kill pathogens, but there are many more ways to help cure infections, and we need to focus on them in the era of drug-resistant bacteria."

Related Links:
Emory University



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Automated Cell Culture Chemistry Analyzer
BioProfile FLEX2 Basic
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.